We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Avantor Inc (AVTR) USD0.01

Sell:$38.74 Buy:$38.75 Change: $0.16 (0.41%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.16 (0.41%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.16 (0.41%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Avantor, Inc. is a global provider of mission critical products and services to customers in the biopharma, healthcare, education and government, and applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.

Contact details

Building One
100 W Matsonford Rd Ste 200
United States
+1 (610) 3861700

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$23.23 billion
Shares in issue:
607.59 million
Life Sciences Tools & Services
New York Stock Exchange
United States
US dollar

Key personnel

  • Michael Stubblefield
    President, Chief Executive Officer, Director
  • Thomas Szlosek
    Chief Financial Officer, Executive Vice President
  • Meghan Henson
    Chief Human Resource Officer, Executive Vice President
  • Eric McAllister
    Chief Human Resource Officer, Executive Vice President
  • Michael Wondrasch
    Executive Vice President, Chief Information Officer
  • Justin Miller
    Executive Vice President, General Counsel, Secretary
  • James Bramwell
    Executive Vice President - Strategic Partners
  • Gerard Brophy
    Executive Vice President - Biopharma Production
  • Christophe Couturier
    Executive Vice President - Services, Strategy and Business Transformation
  • Tanya Foxe
    Executive Vice President - Global Operations and Supply Chain

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.